Efficacy of antiplatelets in deep venous thrombosis

0
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

The impact of air pollution

0
Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...

Quick Q&A with Katherine Higgins MPS

0
Jennifer Cooke, the Editor of Australian Pharmacist, talks with Katherine Higgins, a pharmacist in South Perth, Western Australia.

Psychotropic self-poisoning on the rise in youth

0
A new retrospective cohort study has found that self-poisoning, by ingesting psychotropic medicines, in Australian children and adolescents is increasing. The prescribed medicines...

Pharmacy Board’s measured step on prescribing

0
The Pharmacy Board of Australia has recognised that pharmacists should be able to prescribe under two monitored models of prescribing, in a move welcomed...

COVID-19 spreading locally

0
Health authorities have urged Australians returning from Iran to self-quarantine for 14 days as Australia reports its first cases of human-to-human transmission of COVID-19. There...